Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,790
Closed -$593K 312
2025
Q3
$593K Buy
+8,790
New +$584K 0.02% 239
2017
Q3
Sell
-120,250
Closed -$5.46M 400
2017
Q2
$5.46M Sell
120,250
-24,360
-17% -$1.08M 0.18% 169
2017
Q1
$6.15M Buy
144,610
+31,510
+28% +$1.28M 0.19% 164
2016
Q4
$4.54M Buy
+113,100
New +$4.36M 0.14% 196
2016
Q2
Sell
-341,480
Closed -$11.8M 383
2016
Q1
$11.8M Sell
341,480
-121,840
-26% -$4.25M 0.37% 70
2015
Q4
$17.9M Buy
463,320
+343,970
+288% +$13.4M 0.54% 42
2015
Q3
$4.67M Sell
119,350
-4,000
-3% -$159K 0.15% 165
2015
Q2
$4.7M Sell
123,350
-16,700
-12% -$585K 0.13% 191
2015
Q1
$4.63M Buy
+140,050
New +$4.3M 0.11% 205

Other funds holding HOLX

Castleark Management's HOLX Position: Q4 2025 in Review

Castleark Management sold out of Hologic (HOLX) in Q4 2025, closing a stake of 8,790 shares — an estimated $593K sold.

Castleark Management first reported a position in HOLX in Q1 2015 and held it in 9 quarters. The position peaked at $17.9M in Q4 2015. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Castleark Management reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Castleark Management sold 8,790 Hologic shares in Q4 2025, an estimated $593K.
  • Castleark Management first reported a position in Hologic in Q1 2015 and held it in 9 quarters.
  • Castleark Management's Hologic position peaked at $17.9M in Q4 2015.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Castleark Management's 13F filing for Q4 2025, filed 13 Feb 2026.